63 filings
Page 3 of 4
F-1
mqgl66m40enuwlck8lg
21 Jan 22
Registration statement (foreign)
5:20pm
UPLOAD
055y8
20 Jan 22
Letter from SEC
12:00am
DRS
w85qsbs w82vu
14 Jan 22
Draft registration statement
12:00am
6-K
idokdai mf9xpgkpo4
6 Jan 22
Mainz Biomed Acquires Exclusive Rights to Novel mRNA Biomarkers
8:00am
6-K
fskn5vsh1 025r6
12 Nov 21
MYNZ Shares Have Commenced Trading on the Nasdaq Capital Market
3:45pm
424B3
fa6gzr6dk91 j4qnui1e
12 Nov 21
Prospectus supplement
3:22pm
424B3
2m8pnvmgqemcf51o
12 Nov 21
Prospectus supplement
2:58pm
EFFECT
dqpe77h8
5 Nov 21
Notice of effectiveness
12:15am
CERT
fy3t l2m5g
3 Nov 21
Certification of approval for exchange listing
2:42pm
8-A12B
dpjmu2hk
3 Nov 21
Registration of securities on exchange
8:12am
CORRESP
kntna
2 Nov 21
Correspondence with SEC
12:00am
CORRESP
5bohco8r2oxbyjn
2 Nov 21
Correspondence with SEC
12:00am
F-1/A
hmiz1h29fn0im0v
1 Nov 21
Registration statement (foreign) (amended)
9:11pm
FWP
mktc2 4qw
26 Oct 21
Free writing prospectus
3:19pm
F-1/A
jlalbtjdj0hnm kec887
26 Oct 21
Registration statement (foreign) (amended)
11:22am
UPLOAD
j1w vib2trh4e9u7j
21 Oct 21
Letter from SEC
12:00am
F-1
1jqe qqg3e8c
12 Oct 21
Registration statement (foreign)
12:00am
CORRESP
xn06d s8cnfirbiy3jp0
8 Oct 21
Correspondence with SEC
12:00am
D
s1sb2u2mcfn 9jt
8 Sep 21
Indefinite amount in equity / options, sold $603K, 8 investors
1:13pm
DRS/A
79mbnja7ixee
3 Sep 21
Draft registration statement (amended)
12:00am